Search results
AstraZeneca endometrial cancer treatment recommended for EU approval
ShareCast· 9 hours agoAstraZeneca announced on Monday that ‘Imfinzi’, or durvalumab, and ‘Lynparza’, or olaparib, have...
AstraZeneca's COVID prevention drug application gets EU fast-track assessment
Reuters via Yahoo Finance UK· 10 hours ago"The EMA's (European Medicines Agency) Committee for Medicinal Products for Human Use(CHMP) granted...
AstraZeneca posts mixed results from recent Imfinzi trials
ShareCast· 6 days agoAstraZeneca announced contrasting results from two phase three trials involving its immunotherapy...
AstraZeneca disappointed with failure of immunotherapy in early-stage lung cancer
Proactive Financial News· 6 days agoAstraZeneca PLC (LSE:AZN) shared some disappointing news on an advanced lung cancer trial of its...
AstraZeneca's Imfinzi fails in late-stage trial to treat certain type of lung cancer
Reuters· 6 days agoAstraZeneca said on Tuesday its blockbuster cancer drug, Imfinzi, failed to improve disease-free survival in a late-stage trial to treat a type of early-stage lung cancer.
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Zacks via Yahoo Finance UK· 5 days agoData from a late-stage study shows that treatment with AstraZeneca's (AZN) Imfinzi plus chemotherapy...
AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung...
Benzinga via Yahoo Finance UK· 6 days agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADJUVANT BR.31 Phase 3...
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Reuters· 5 days agoAstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based...
TOP NEWS: AstraZeneca details mixed findings from cancer drug trials
Morningstar· 6 days agoShares in AstraZeneca rose 0.6% to 12,548.00 pence on Tuesday morning. The Cambridge-based pharmaceutical company said Imfinzi met both its primary and secondary aims in a trial on sufferers of bladder cancer.
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
Zacks via Yahoo Finance UK· 3 days agoThis Score examines things like projected and historical earnings, sales, and cash flow to find...